These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32030107)

  • 1. Cell Communication Network Factor 4 (CCN4/WISP1) Shifts Melanoma Cells from a Fragile Proliferative State to a Resilient Metastatic State.
    Deng W; Fernandez A; McLaughlin SL; Klinke DJ
    Cell Mol Bioeng; 2020 Feb; 13(1):45-60. PubMed ID: 32030107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
    Deng W; Fernandez A; McLaughlin SL; Klinke DJ
    J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma.
    Fernandez A; Deng W; McLaughlin SL; Pirkey AC; Rellick SL; Razazan A; Klinke DJ
    EMBO Rep; 2022 Apr; 23(4):e54127. PubMed ID: 35099839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of CCN4/WISP1 Effects on Joint Tissues Using Gain- and Loss-of-Function Approaches.
    van den Bosch MHJ; Blaney Davidson EN
    Methods Mol Biol; 2023; 2582():369-390. PubMed ID: 36370364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-Head Comparison of CCN4, DNMT3A, PTPN11, and SPARC as Suppressors of Anti-tumor Immunity.
    Pirkey AC; Deng W; Norman D; Razazan A; Klinke DJ
    Cell Mol Bioeng; 2023 Dec; 16(5-6):431-442. PubMed ID: 38099213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of CCN4 (WISP1) role in human diseases.
    Singh K; Oladipupo SS
    J Transl Med; 2024 Jun; 22(1):601. PubMed ID: 38937782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and physiological role of CCN4/Wnt-induced secreted protein 1 mRNA splicing variants in chondrocytes.
    Yanagita T; Kubota S; Kawaki H; Kawata K; Kondo S; Takano-Yamamoto T; Tanaka S; Takigawa M
    FEBS J; 2007 Apr; 274(7):1655-65. PubMed ID: 17381509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor cell-secreted matricellular protein WISP1 drives pro-metastatic collagen linearization.
    Jia H; Janjanam J; Wu SC; Wang R; Pano G; Celestine M; Martinot O; Breeze-Jones H; Clayton G; Garcin C; Shirinifard A; Zaske AM; Finkelstein D; Labelle M
    EMBO J; 2019 Aug; 38(16):e101302. PubMed ID: 31294477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal CCN4 Immunofluorescence for Tissue Microarray.
    Gaudreau PO; Cousineau I; Stagg J
    Methods Mol Biol; 2023; 2582():13-21. PubMed ID: 36370340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCN4/WISP1 controls cutaneous wound healing by modulating proliferation, migration and ECM expression in dermal fibroblasts via α5β1 and TNFα.
    Ono M; Masaki A; Maeda A; Kilts TM; Hara ES; Komori T; Pham H; Kuboki T; Young MF
    Matrix Biol; 2018 Aug; 68-69():533-546. PubMed ID: 29330021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone.
    Ono M; Inkson CA; Sonn R; Kilts TM; de Castro LF; Maeda A; Fisher LW; Robey PG; Berendsen AD; Li L; McCartney-Francis N; Brown AC; Crawford NP; Molinolo A; Jain A; Fedarko NS; Young MF
    PLoS One; 2013; 8(8):e71709. PubMed ID: 23977121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WISP1/CCN4 aggravates cartilage degeneration in experimental osteoarthritis.
    van den Bosch MH; Blom AB; Kram V; Maeda A; Sikka S; Gabet Y; Kilts TM; van den Berg WB; van Lent PL; van der Kraan PM; Young MF
    Osteoarthritis Cartilage; 2017 Nov; 25(11):1900-1911. PubMed ID: 28735021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aneurysm severity is suppressed by deletion of CCN4.
    Williams H; Wadey KS; Frankow A; Blythe HC; Forbes T; Johnson JL; George SJ
    J Cell Commun Signal; 2021 Sep; 15(3):421-432. PubMed ID: 34080128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Picking a bone with WISP1 (CCN4): new strategies against degenerative joint disease.
    Maiese K
    J Transl Sci; 2016; 1(3):83-85. PubMed ID: 26893943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WISP 1 is an important survival factor in human mesenchymal stromal cells.
    Schlegelmilch K; Keller A; Zehe V; Hondke S; Schilling T; Jakob F; Klein-Hitpass L; Schütze N
    Gene; 2014 Nov; 551(2):243-54. PubMed ID: 25200494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer.
    Gurbuz I; Chiquet-Ehrismann R
    Int J Biochem Cell Biol; 2015 May; 62():142-6. PubMed ID: 25794425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity.
    Ferrand N; Béreziat V; Moldes M; Zaoui M; Larsen AK; Sabbah M
    Sci Rep; 2017 May; 7(1):1749. PubMed ID: 28496206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CCN4/WISP-1 in the cancerous phenotype.
    Nivison MP; Meier KE
    Cancer Manag Res; 2018; 10():2893-2903. PubMed ID: 30214284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRE1 inhibition affects the expression of insulin-like growth factor binding protein genes and modifies its sensitivity to glucose deprivation in U87 glioma cells.
    Minchenko DO; Kharkova AP; Tsymbal DO; Karbovskyi LL; Minchenko OH
    Endocr Regul; 2015 Oct; 49(4):185-97. PubMed ID: 26494037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WISP1 overexpression promotes proliferation and migration of human vascular smooth muscle cells via AKT signaling pathway.
    Lu S; Liu H; Lu L; Wan H; Lin Z; Qian K; Yao X; Chen Q; Liu W; Yan J; Liu Z
    Eur J Pharmacol; 2016 Oct; 788():90-97. PubMed ID: 27321870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.